Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Linical Co's Pre-Tax Income for the
six
months ended in Mar. 2026 was 円-2,471 Mil. Linical Co's Revenue for the
six
months ended in Mar. 2026 was 円3,806 Mil. Therefore, Linical Co's pretax margin for the quarter that ended in Mar. 2026 was -64.91%.
The historical rank and industry rank for Linical Co's Pretax Margin % or its related term are showing as below:
TSE:2183'
s Pretax Margin % Range Over the Past 10 Years
Min: -34.78 Med: 8.16 Max: 24.06
Current: -34.78
TSE:2183's Pretax Margin % is ranked better than 59.96% of 944
companies
in the Biotechnology industry
Industry Median: -90.5
vs TSE:2183: -34.78
Linical Co (TSE:2183) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Linical Co Pretax Margin % Related Terms
Linical Co Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Linical Co's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:2183 vs VRTX, REGN, ALNY: Pretax Margin % Comparison
For the Biotechnology subindustry, Linical Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Linical Co Pretax Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Linical Co's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Linical Co's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Linical Co (TSE:2183) has a Pretax Margin % of -64.91% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Linical Co and its competitors. According to the industry distribution chart, Linical Co ranks #378 out of 944 companies in the Biotechnology industry, placing it in the top 40%.
Is Linical Co's Pretax Margin % too high?
Linical Co's current Pretax Margin % is -64.91%. Based on the distribution chart, Linical Co ranks #378 out of 944 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Linical Co has a GF Score™ of 48/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Linical Co's Pretax Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Linical Co ranks #378 out of 944 companies for Pretax Margin %. This puts Linical Co in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Linical Co and its competitors. Linical Co's current Pretax Margin % is -64.91%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Linical Co stock overvalued right now?
Based on GuruFocus' analysis, Linical Co (TSE:2183) is currently considered Possible Value Trap. The stock's GF Value™ is 円310.47, compared to a current price of 円202.00 — trading 34.9% below its estimated fair value. The current Pretax Margin % is -64.91%. Linical Co's overall GF Score™ is 48/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Linical Co (TSE:2183), the current Pretax Margin % is -64.91% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Linical Co (TSE:2183) Overvalued in 2026?
Based on GuruFocus' analysis, Linical Co stock appears to be undervalued.
The current stock price of 円202.00 is trading 34.9% below its estimated GF Value™ of 円310.47.
GuruFocus considers Linical Co to be Possible Value Trap.
Key valuation signals for TSE:2183:
Pretax Margin %: -64.91%
GF Value™: 円310.47 vs. price of 円202.00 (34.9% below fair value)
No single metric tells the full story. See the TSE:2183 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2183 has been successfully added to your 
